|
FNDC3B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.985500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.603600E-01 |
| Normal-vs-Stage2 |
1.682630E-01 |
| Normal-vs-Stage3 |
5.316200E-02 |
| Normal-vs-Stage4 |
3.377800E-01 |
| Stage1-vs-Stage2 |
4.256800E-01 |
| Stage1-vs-Stage3 |
6.424400E-02 |
| Stage1-vs-Stage4 |
4.188000E-01 |
| Stage2-vs-Stage3 |
5.072800E-01 |
| Stage2-vs-Stage4 |
5.575600E-01 |
| Stage3-vs-Stage4 |
7.359600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.757600E-02 |
| Normal-vs-AfricanAmerican |
1.224610E-01 |
| Normal-vs-Asian |
8.028000E-01 |
| Caucasian-vs-AfricanAmerican |
9.631600E-01 |
| Caucasian-vs-Asian |
6.897600E-01 |
| AfricanAmerican-vs-Asian |
5.820600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.615000E-01 |
| Normal-vs-Female |
1.124410E-03 |
| Male-vs-Female |
1.964190E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.091200E-01 |
| Normal-vs-Extreme_Weight |
8.408400E-01 |
| Normal-vs-Obese |
2.537800E-02 |
| Normal-vs-Extreme_Obese |
8.904000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.438600E-01 |
| Normal_Weight-vs-Obese |
5.125800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.349000E-01 |
| Extreme_Weight-vs-Obese |
1.393860E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.913400E-01 |
| Obese-vs-Extreme_Obese |
2.615400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.068000E-02 |
| Normal-vs-Age(41-60Yrs) |
8.957100E-03 |
| Normal-vs-Age(61-80Yrs) |
5.754400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.978800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.095400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.039500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.014000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.702500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.203070E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.518210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.056600E-01 |
| Normal-VS-Type2 PRCC |
8.209200E-01 |
| Normal-VS-KIRP CIMP |
4.634000E-02 |
| Normal-VS-Unclassified PRCC |
4.877300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.461640E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.868000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.836300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
4.864500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.897300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.735440E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.887000E-01 |
| Normal-vs-N1 |
8.476900E-03 |
| Normal-vs-N2 |
3.790000E-01 |
| N0-vs-N1 |
1.019650E-02 |
| N0-vs-N2 |
3.875000E-01 |
| N1-vs-N2 |
5.907000E-01 |
|
|
